|
Save the Date!
Next Patient Workshop
Sunday
February 19, 2012
Hilton Dallas-Fort Worth, Texas Lakes Executive Conference Center.
Details regarding registration will be posted on the CIR website soon.
| | | |
|
Therapy Tip
It's common for patients who are chronically ill to have a low hemoglobin (Hgb) and hematocrit (Hct) due to anemia of chronic disease. It's also not unusual for Hgb and Hct to decrease during Inflammation Therapy due to Herxheimer reactions. If Hgb falls to 11 and/or Hct falls to 28, the immune response should be slowed down by managing all aspects of IT.
| | |
| Our Library |
Access to our extensive, easy-to-read Library of Information (see this sample page)and Physicians' Reference Library is available to anyone, without enrollment in our counseling program. A list of the articles in our library is available at this link. Physicians may use CIR libraries even if they don't have a patient enrolled in our counseling program. Interested medical professionals should contact CIR and ask to register.  If you're interested in using this resource, please send your request to our email, along with your doctor's name and fax number (in the US and Canada) and his/her email address so we can notify your doctor that you have access to this information. |
CIR Organization
CIR is an IRS-recognized
501(c)3 non-profit, charitable organization. Donations allow us to fulfill our mission and every gift is appreciated. Donate Online Here | |
|
Survey
Volunteers who have a diagnosis of autoimmune or inflammatory disease or are chronically ill but who are not being treated with Inflammation Therapy, the Marshall Protocol or the Stillpoint Protocol are needed to be in the control group of our clinical study.
If you meet these criteria and would like to take part in this project (which will only take a few minutes once a month), please contact us
via email.
| | | |
| Contact Information | CIR email address
Phone CIR toll-free
in the US and Canada
1-888-846-2474
Are you a Skype User?
Look for
Chronic.Illness.Recovery
|
|
|
 |
|
Greetings!
Often patients ask us how they can help. A good way to lend a hand is by telling your doctor that CIR has a website with helpful resources for medical practitioners using Inflammation Therapy. For example, doctors have shared the documentation they use to help streamline management of this treatment.
Doctors who authorize CIR counseling for a patient may choose their level of involvement. At a minimum, they will receive their patient's reports with the nurse's responses so they know what advice is being given and have a hard copy for their clinic record. They can also rely on us to let them know if we think a patient is in trouble.
Experienced doctors share their expertise with other clinicians by posting in our secure, private Physicians' Forum. Less experienced physicians may ask questions about the science, specific patients or therapy management.
Plans are being finalized for a CME-approved seminar for medical practitioners to be held Saturday, February 18, 2012 at the Hilton Dallas-Fort Worth Lakes Executive Conference Center. Please ask your doctor if s/he is receiving our professional newsletter via email and encourage him/her to attend the seminar.
Thanks for helping spread the word about CIR and IT.
Warm regards,
 
|
|
About Inflammation Therapy | |
The anemia of chronic disease is not due to iron deficiency and will not be helped by iron supplements. In fact, iron supplements are counter-productive because iron will help L-form bacteria multiply. It's important to differentiate between Iron Deficiency Anemia (IDA) and anemia of chronic disease.
Anemia of chronic disease and iron deficiency anemia, the most common forms of anemia, are differentiated primarily by estimates of iron status. Standard measures of iron status, such as ferritin, total iron-binding capacity, and serum iron are directly affected by chronic disease. In contrast, soluble transferrin receptor (sTfR) is elevated in iron deficiency but is not appreciably affected by chronic disease.
To identify iron deficiency anemia, hemoglobin must be measured together with more selective measurements of iron status. The following tests are needed for a differential diagnosis:
- serum ferritin
- serum iron
- total iron binding capacity (TIBC; an indirect reflection of the transferrin level)
- percent transferrin saturation (calculated from the serum iron and the TIBC)
- soluble transferrin receptor (sTfR)
All of these tests reflect slightly different aspects of internal iron metabolism and give the most complete picture of the iron status of the patient.
Anemia of chronic disease equals:
- ferritin normal or high
- iron low
- normal to low soluble transferrin receptor (sTfR)
- normal to low total iron-binding capacity (TIBC)
|
|
Patient Workshop | |
Our day-long patient workshop to be held Sunday, February 19, 2012 at the Hilton Dallas-Fort Worth Lakes Executive Conference Center will begin with a delicious breakfast buffet. Presentations will include the basics of Inflammation Therapy, a primer on the science of IT, a session of Q&A with a panel of doctors, several recovery reports by experienced patients, and a choice of round table discussions on family support or methods of coping during the recovery process.
Morning and afternoon breaks are included and a long lunch will provide more opportunity for patients to communicate with each other. Those who arrive on Saturday may attend the optional reception/dinner Saturday evening to meet CIR staff, other patients and some of the physicians who attended the seminar. |
|
New Scientific Article | |
The Struggle for Iron - A Metal at the Host-Pathogen Interface
"This review summarizes our current knowledge on the combat of host cells and pathogens for the essential nutrient iron focusing on the immune-regulatory roles of iron on cell-mediated immunity necessary to control intracellular microbes, the host's mechanisms of iron restriction and on the counter-acting iron-acquisition strategies employed by intracellular microbes."
Published in the December 2010 issue of Cell Microbiology.
See our related Library of Information article on our website. |
| Quotable Quotes | |
"I've found this site really helpful indeed. The nurses are great!"
- Anna
"I'm so relieved and thankful to have found Inflammation Therapy and CIR."
-Rachel
Lida Mattman was a pioneer who found tuberculosis patients' blood was saturated with a variety of L-form bacteria. She ultimately found L-forms in patients with over 20 incurable diseases, including: Parkinson's disease, Lyme disease, multiple sclerosis and sarcoidosis. Her most in-depth studies related to L-Forms spontaneously occurring in vivo and in vitro. Mattman published numerous papers and the textbook Cell Wall Deficient Forms: Stealth Pathogens. She had a long career and continued working into her nineties before she died in 2008.
.
|
|
|
|
|
